1. PCSK9 is not secreted from mature differentiated intestinal cells
- Author
-
Melissa Touvron, Cédric Le May, Thibaud Sotin, Xavier Prieur, L. Arnaud, Annik Prat, Anna Roubtsova, Claire Blanchard, Nabil G. Seidah, Wieneke Dijk, Audrey Ayer, Moreau François, Bertrand Cariou, Laurianne Van Landeghem, Gilliane Chadeuf, Damien Garçon, Aurélie Thedrez, Mikaël Croyal, Unité de recherche de l'institut du thorax (ITX-lab), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Université de Montréal (UdeM), Centre hospitalier universitaire de Nantes (CHU Nantes), North Carolina State University [Raleigh] (NC State), University of North Carolina System (UNC), Dijk, Wieneke, unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherches Cliniques de Montréal (IRCM), and Le May, Cedric
- Subjects
[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,[SDV]Life Sciences [q-bio] ,3′DGE, 3′ digital gene expression ,Regulator ,030204 cardiovascular system & hematology ,Biochemistry ,Caco-2 cell ,PCSK9 ,Mice ,0302 clinical medicine ,Endocrinology ,Intestine, Small ,liver-specific knockout ,Cells, Cultured ,ComputingMilieux_MISCELLANEOUS ,portal blood ,Mice, Knockout ,[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism ,lipoprotein metabolism ,0303 health sciences ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,medicine.diagnostic_test ,Chemistry ,Cell Differentiation ,[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Cell biology ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,WB, Western blot ,Kexin ,Proprotein Convertase 9 ,Corrigendum ,Research Article ,DEGs, differentially expressed genes ,Mice, Transgenic ,QD415-436 ,Ussing chambers ,endoH, endoglycosidase H ,TICE, trans-intestinal cholesterol excretion ,03 medical and health sciences ,Western blot ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,medicine ,[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO] ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Animals ,Humans ,Secretion ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,PCSK9 LivKO, mouse model lacking PCSK9 specifically in hepatocytes ,intestine ,030304 developmental biology ,PPL, postprandial lipemia ,systemic blood ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Cell Biology ,Proprotein convertase ,[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Small intestine ,Mice, Inbred C57BL ,LDL receptor ,cholesterol metabolism ,Caco-2 Cells ,PCSK9, proprotein convertase subtilisin/kexin type 9 ,PNGase F, N-glycosidase F ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes lysosomal degradation of the LDL receptor and is a key regulator of cholesterol metabolism. After the liver, the small intestine is the second organ that highly expresses PCSK9. However, the small intestine's ability to secrete PCSK9 remains a matter of debate. While liver-specific PCSK9-deficient mice present no PCSK9 in systemic blood, human intestinal Caco-2 cells can actively secrete PCSK9. This raises the possibility for active intestinal secretion via the portal blood. Here, we aimed to determine whether enterocytes can secrete PCSK9 using in vitro, ex vivo, and in vivo approaches. We first observed that PCSK9 secretion from Caco-2 cells was biphasic and dependent on Caco-2 maturation status. Transcriptional analysis suggested that this transient reduction in PCSK9 secretion might be due to loss of SREBP2-mediated transcription of PCSK9. Consistently, PCSK9 secretion was not detected ex vivo in human or mouse intestinal biopsies mounted in Ussing chambers. Finally, direct comparison of systemic versus portal blood PCSK9 concentrations in WT or liver-specific PCSK9-deficient mice confirmed the inability of the small intestine to secrete PCSK9 into the portal compartment. Altogether, our data demonstrate that mature enterocytes do not secrete PCSK9 and reinforce the central role of the liver in the regulation of the concentration of circulating PCSK9 and consequently of cellular LDL receptors.
- Published
- 2021